Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2022-05-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-014492
- Form type
- SC 13G
- Filer
- Commodore Capital LP
- CIK
- CIK 1831942
- Filed
- May 19, 2022
- Reporting period
- May 09, 2022
- Description
- Schedule 13G beneficial ownership